当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析

南京医药

(600713)

  

流通市值:65.50亿  总市值:66.62亿
流通股本:12.87亿   总股本:13.09亿

南京医药(600713)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.30亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益795822.64万元,未分配利润282977.00万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3404505.42万元,负债2608682.78万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入41,135,141,888.4727,967,411,701.6214,246,884,352.753,696,173,895.8
营业总成本40,346,990,541.2127,397,599,436.3113,943,368,597.8352,651,384,912.88
其他经营收益
营业利润691,410,392.7508,182,105.47274,943,946.691,023,404,107.29
利润总额708,545,653.09526,853,483.18276,335,599.731,003,395,388.5
净利润529,756,573.09379,749,529.44215,583,457.34743,119,993.89
每股收益
其他综合收益-2,406,240.26-1,489,536.52-7,229,191.8512,772,851.86
综合收益总额527,350,332.83378,259,992.92208,354,265.49755,892,845.75
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计31,003,426,359.1530,188,607,618.6430,516,521,104.427,807,861,740.6
非流动资产:
非流动资产合计3,041,627,824.33,017,187,526.332,962,928,150.982,865,765,191.92
资产总计34,045,054,183.4533,205,795,144.9733,479,449,255.3830,673,626,932.52
流动负债:
流动负债合计21,445,543,07220,696,678,755.5819,627,239,754.7617,093,712,526.91
非流动负债:
非流动负债合计4,641,284,714.854,655,121,729.735,845,649,822.235,792,016,291.6
负债合计26,086,827,786.8525,351,800,485.3125,472,889,576.9922,885,728,818.51
所有者权益(或股东权益):
归属于母公司股东权益合计6,974,165,868.166,859,580,954.357,018,676,593.36,838,027,007.12
股东权益合计7,958,226,396.67,853,994,659.668,006,559,678.387,787,898,114.01
负债和股东权益合计34,045,054,183.4533,205,795,144.9733,479,449,255.3830,673,626,932.52
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计37,487,515,677.9524,033,009,722.7311,984,973,339.1556,586,023,183.9
经营活动现金流出小计42,464,250,146.228,064,489,463.1115,585,412,464.5554,450,257,768.5
经营活动产生的现金流量净额-4,976,734,468.25-4,031,479,740.38-3,600,439,125.42,135,765,415.4
投资活动产生的现金流量:
投资活动现金流入小计970,217,531.21835,917,651.47970,426.9610,434,012.42
投资活动现金流出小计1,426,192,879.451,049,494,571407,566,651.24572,360,104.06
投资活动产生的现金流量净额-455,975,348.24-213,576,919.53-406,596,224.28-561,926,091.64
筹资活动产生的现金流量:
筹资活动现金流入小计18,557,106,925.114,998,953,182.938,435,822,069.1921,178,888,465.41
筹资活动现金流出小计14,960,529,499.3812,001,819,598.685,655,040,239.5822,018,660,463.48
筹资活动产生的现金流量净额3,596,577,425.722,997,133,584.252,780,781,829.61-839,771,998.07
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,836,132,390.77-1,247,923,075.66-1,226,253,520.07734,067,325.69
期末现金及现金等价物余额1,092,004,065.781,680,213,380.891,701,882,936.482,928,136,456.55
补充资料:
现金及现金等价物的净增加额--1,247,923,075.66-734,067,325.69
TOP↑